Biosynthetic Gas Vesicles Combined with Focused Ultrasound for Blood–Brain Barrier Opening

Abstract

Our study suggests that biosynthetic GVs hold great potential to serve as local BBB-opening agents in the development of new targeted drug delivery strategies for central nervous system disorders.